m-PEG8-O-alkyne
CAS No. 880081-81-2
m-PEG8-O-alkyne( —— )
Catalog No. M26977 CAS No. 880081-81-2
m-PEG8-O-alkyne is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | 31 | In Stock |
|
| 50MG | 45 | In Stock |
|
| 100MG | 67 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Namem-PEG8-O-alkyne
-
NoteResearch use only, not for human use.
-
Brief Descriptionm-PEG8-O-alkyne is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
-
Descriptionm-PEG8-O-alkyne is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.(In Vitro):PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.
-
In VitroPROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorIL-6| Interleukin| STAT3
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number880081-81-2
-
Formula Weight422.515
-
Molecular FormulaC20H38O9
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : ≥ 100 mg/mL (236.68 mM)
-
SMILESCOCCOCCOCCOCCOCCOCCOCCOCCOCC#C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Ianalumab
Ianalumab (VAY-736) is a decarboxylated humanized antibody against BAFF-R that inhibits the interaction between BAFF and BAFF-R, blocking BAFF-mediated apoptosis protection.
-
2,3,4,6-Tetra-o-acet...
2,3,4,6-Tetra-o-acetyl-alpha-galactosylpyranosyl bromide is an alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs.
-
DCZ0415
DCZ0415 induces antimyeloma activity in vitro, in vivo and in primary cells of drug-resistant myeloma patients. DCZ0415 is a potent TRIP13 inhibitor that can impair the repair of non-homologous end junctions and inhibit NF-κB activity.DCZ0415 (10, 20 μM; 72 hours) showed a marked reduction in colony formation, indicating that it inhibited cell proliferation.
Cart
sales@molnova.com